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Specialty Update
What’s New in Adult Reconstructive
Knee Surgery
Carl A. Deirmengian, MD, and Jess H. Lonner, MD
The purpose of this review is to summarize studies on various
topics in adult knee reconstruction that were published during
the year 2010. The keywords ‘‘knee’’ and ‘‘arthroplasty’’ and
‘‘prospective’’ and ‘‘randomized’’ were used to perform a search
of the National Library of Medicine’s PubMed database; the
search was limited to studies that were published in The Journal
of Bone and Joint Surgery (American Volume) or The Journal of
Arthroplasty in 2010. The resulting seventeen studies are in-
cluded in this review of adult reconstruction of the knee and are
included in the complete bibliography at the end of the man-
uscript. In addition, other studies from 2010 were chosen for
their specific relevance to the topics being discussed.
Epidemiology and Economic Factors
Continuing research into the epidemiology and economics
of adult hip and knee arthroplasty has improved our under-
standing of costs, processes of care, and outcomes. Data related
to these topics are ever important in a time when standards and
mandates of care are being generated by various administrative
bodies. As health care protocols and recommended processes
of care are generated, there is a clear need to validate decisions
that affect entire populations of patients.
Bozic et al.1 used the Perspective database to identify
182,146 patients managed with primary hip and knee arthro-
plasty in order to assess the independent effects of surgeon
volume, hospital volume, and process standardization on
short-term outcomes. The authors used adherence to antibiotic
prophylaxis, the appropriate use of perioperative beta-blockers,
and venous thromboembolism prophylaxis as a proxy for care
that was provided with process standardization. As expected,
both surgeon volume and hospital volume were associated with
significant improvements in short-term outcomes, including
reduced complication rates, reduced rates of reoperations and
readmissions, reduced mortality, and reduced length of hos-
pital stay. In addition, the authors found that process stan-
dardization was independently responsible for reduced length
of hospital stay and improved short-term outcomes. Given the
increasing volume of adult hip and knee arthroplasty proce-
dures, many practices and hospitals are instituting standardized
protocols of care to improve the efficiency of care while re-
ducing the likelihood of suboptimal care. Although few would
argue that adherence to antibiotic and thromboembolism
prophylaxis and beta blocker management alone would explain
the author’s findings, consistency in meeting these standards of
care is likely a marker for programs that provide efficient and
optimal care for hip and knee arthroplasty patients.
Bini et al.2 focused on the readmission rate after primary
hip and knee arthroplasty in relation to patient discharge dis-
position. They wanted to understand the relative complication
rate in patients who were discharged to a skilled nursing facility
as compared with patients who were discharged to home. The
Kaiser Permanente Total Joint Replacement Registry was uti-
lized to identify 9150 patients managed with primary hip and
knee arthroplasty who had an American Society of Anesthe-
siologists (ASA) score of £2 and were discharged without an
inpatient complication. The authors isolated these patients in
an effort to minimize the patient selection that could bias to-
ward having sicker patients at a skilled nursing facility. Inter-
estingly, patients who were discharged to a skilled nursing
facility had an almost twofold increase in readmissions after
primary hip and knee arthroplasty, even after controlling for
ASA score, age, sex, and in-hospital complications. The authors
admitted that, despite their efforts, the observed effect may
Specialty Update has been developed in collaboration with the Board of
Specialty Societies (BOS) of the American Academy of Orthopaedic Surgeons.
Disclosure:None of the authors received payments or services, either directly or indirectly (i.e., via his or her institution), from a third party in support of any
aspect of this work. One or more of the authors, or his or her institution, has had a financial relationship, in the thirty-six months prior to submission of this
work, with an entity in the biomedical arena that could be perceived to influence or have the potential to influence what is written in this work. No author has
had any other relationships, or has engaged in any other activities, that could be perceived to influence or have the potential to influence what is written in
this work. The complete Disclosures of Potential Conflicts of Interest submitted by authors are always provided with the online version of the article.
182
COPYRIGHT  2012 BY THE JOURNAL OF BONE AND JOINT SURGERY, INCORPORATED
J Bone Joint Surg Am. 2012;94:182-8 d http://dx.doi.org/10.2106/JBJS.K.01262
result from patient selection, with ‘‘sicker’’ patients being more
likely to be discharged to a skilled nursing facility. Given the
clinical importance of the findings, it is prudent to follow pa-
tients closely even when they are discharged to a skilled nursing
facility.
When considering the trend toward decreasing reim-
bursement in health care, combined with the increasing need
for joint arthroplasty, there is obvious reason to be concerned
that patient access to hip and knee arthroplasty procedures will
be at risk. Fehring et al.3 defined the supply side of arthroplasty
access by describing the predicted workforce of joint replace-
ment surgeons over the next six years. The American Academy
of Orthopaedic Surgeons (AAOS) database and the 2004 and
2006 AAOS Orthopaedic Practice in the United States Surveys
(OPUS) were used to generate data regarding the inflow and
outflow of arthroplasty surgeons from the workforce. The
National Inpatient Sample (NIS) was used to generate data to
predict the number of hip and knee arthroplasties likely to be
demanded over the same time period. By the year 2016, 1896
arthroplasty surgeons will retire if sixty-five years is used as the
retirement age whereas 4239 arthroplasty surgeons will retire if
fifty-nine years is used as the retirement age. In comparison,
only 400 arthroplasty surgeons will join the workforce by 2016.
This disparity in surgeons is predicted to yield a shortfall of
174,409 procedures if sixty-five years is used as the retirement
age as compared with a shortfall of 1,177,761 if fifty-nine years
is used as the retirement age. The authors expressed concern
over the supply side crisis that threatens patient access to hip
and knee arthroplasty over the next six years. Iorio et al.4 added
data regarding surgeon attitudes and economic trends. They
surveyed a large portion of the American Association of Hip
and Knee Surgeons (AAHKS) regarding attitudes and eco-
nomic challenges that may result from decreasing reimburse-
ments. They found that if Medicare reimbursement were to
decrease by as much as 20%, about half of the AAHKS surgeons
would be unable to provide care for Medicare patients. This
would create an unmet need of >92,000 procedures among
AAHKS surgeons alone. Therefore, considering the increasing
numbers of hip and knee arthroplasty procedures needed, a
supply side crisis that will result in fewer available specialists,
and decreasing reimbursement that will hinder many surgeons’
ability to treat Medicare patients, there is clear reason for se-
rious concern that patient access to hip and knee arthroplasty
will be at serious risk during the next decade.
Venous Thromboembolism
The optimal form of venous thromboprophylaxis after total
knee arthroplasty remains unclear. The main disagreement
continues to revolve around the risk of pulmonary embolism
compared with the risk of perioperative bleeding complica-
tions. Clinical protocols for joint replacement have evolved to
include a faster operative time, rapid postoperative ambulation,
and a multimodal strategy for thromboprophylaxis. The risk
of fatal pulmonary embolism is low enough that prospective
studies of unreasonable magnitude would be required to reveal
significant differences in mortality between drugs.
Bozic et al.5 utilized the Perspective database to identify
93,840 patients who were managed with either aspirin (5%),
warfarin (55%), or injectable agents (40%) over a two-year
period. Statistical tools were utilized to adjust the data for
patient allocation biases that may have driven the use of one
anticoagulant over another. While some centers contributing to
the database utilized aspirin for <5% of patients, others ap-
peared to use aspirin as a standard, with >75% of patients being
managed with aspirin. Analysis of patient groups revealed very
small but significant differences as patients who were managed
with aspirin were slightly less likely to have medical comor-
bidities. The authors found that aspirin was associated with
a lower adjusted risk for venous thromboembolic events in
comparison with warfarin and with a similar adjusted risk for
thromboembolism as compared with injectable agents. Aspirin
also was found to have similar adjusted complication and
mortality rates when compared with warfarin and injectable
agents. The authors also noted that the patients who were
managed with aspirin generally had shorter hospital stays and
more frequently were discharged to home, suggesting that
they were involved in a multimodal strategy promoting rapid
return to walking. Additional studies are needed to demon-
strate the efficacy of aspirin, as well as other drugs, in pre-
venting fatal embolism. Nevertheless, it is interesting to find
that, in such a large retrospective database, the actual drug
utilized for thromboprophylaxis made very little difference to
patient outcomes. Perhaps other factors such as patient pre-
dispositions, surgical techniques, management protocols, and
time to walking outweigh the drug effect on thromboembolic
events.
Fuji et al.6 performed a prospective, randomized, double-
blind, placebo-controlled study in which three doses of oral
dabigatran etexilate (110, 150, or 220 mg, administered once
daily) were compared with placebo. The study included 597
patients undergoing primary total knee arthroplasty. The au-
thors did not allow for intermittent pneumatic compression
devices or antiplatelet drugs in the study. The study revealed
that dabigatran etexilate was effective for reducing asymp-
tomatic deep-vein thrombosis (DVT) (with rates of 39.6%,
32.7%, and 24.0% for the three doses) compared with placebo
(56.4%). The authors stated that the rates of total venous
thromboembolism and all-cause mortality were lower for pa-
tients receiving dabigatran. Interestingly, neither the placebo
group nor the treatment groups included even one case of
death, pulmonary embolism, or symptomatic DVT.
Navigation
The use of computer navigation for total knee arthroplasty has
evolved to become a more efficient and safe procedure. Two
recent publications specifically addressed the potential medical
advantages of using computer navigation, which enables the
surgeon to avoid the use of intramedullary alignment devices.
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O’Connor et al.7 conducted a prospective exploratory
study on the effect of computer navigation on fat emboli after
total knee arthroplasty. Forty-four patients were randomly as-
signed to standard or computer-assisted total knee arthroplasty,
with an intramedullary femoral guide only used in the standard
group. It is important to note that the authors irrigated and
suctioned the femoral canal before instrumentation. Trans-
esophageal echocardiography was utilized to quantify embolic
material passing through the right atrium after tourniquet de-
flation. The authors found very little difference between the
groups, with both standard and computer-assisted total knee
arthroplasties creating similar amounts of fat emboli that passed
through the atrium. The authors concluded that any effect of
computer navigation on minimizing fat emboli is likely to be
clinically unimportant. Haytmanek et al.8 conducted a similar
study in which patients were evaluated for cognitive changes
after standard and computer-assisted total knee arthroplasty.
Theoretically, computer-assisted total knee arthroplasty could
minimize vascular fat emboli and marrow debris, reducing the
rate of cognitive changes after total knee arthroplasty. The study
included forty-seven patients undergoing computer-assisted
total knee arthroplasty and forty-eight patients undergoing
standard total knee arthroplasty. The Folstein mini-mental state
examination was performed before and after surgery. There were
no significant differences between the standard and computer-
assisted total knee arthroplasty groups in terms of pain medi-
cation, oxygen requirements, or the results of the Folstein
examination. The authors concluded that any differences be-
tween standard and computer-assisted total knee arthroplasty in
terms of embolic material produced are likely not clinically
relevant. Although there may be other advantages, the minimi-
zation of embolic material should not be considered an advan-
tage of computer-assisted total knee arthroplasty.
Minimally Invasive Surgery: Approaches to the Knee
The popularity of minimally invasive surgery and the ensuing
clinical research resulted in several advances in knee arthro-
plasty. Multimodal pain protocols emerged, coupled with the
new surgical techniques, providing surgeons with options that
avoid parenteral narcotics and minimize their postoperative
side effects. Additionally, rapid therapy protocols gained trac-
tion, allowing patients to walk soon after surgery and to return
home within days after arthroplasty. Interestingly, while en-
thusiasm for multimodal pain management and rapid therapy
programs continues, there is a general sense that minimally
invasive approaches provide an exceedingly small incremental
benefit for the patient.
The subvastus approach gained popularity as a less-
invasive approach that avoids injury to the quadriceps mech-
anism. Bourke et al.9 conducted a systematic review in which
the outcomes of the medial parapatellar approach were com-
pared with those of the subvastus approach. They identified five
studies that were included by three blinded independent as-
sessors for quality (level III-1 evidence or higher) and suitability
for inclusion in the review. The combined studies included
284 total knee arthroplasties, with similar numbers of proce-
dures having been performed with use of the parapatellar and
subvastus approaches. The authors found that there was no
significant difference between the groups in terms of the length
of hospital stay, the number of days to walking, the range of knee
extension motion, patellar avascular necrosis, or patient pref-
erence. Bonutti et al.10 conducted a prospective randomized
study in which the mini-subvastus approach was compared
with the mini-midvastus approach using a bilateral total knee
arthroplasty model. Fifty-one patients were managed with a
mini-subvastus approach for one total knee arthroplasty and
a simultaneous mini-midvastus approach for the contralateral
total knee arthroplasty. The authors measured isokinetic
strength of the knees at twelve weeks after total knee arthro-
plasty and collected data (including blood loss, knee motion,
patient preference, and Knee Society scores) at two years of
follow-up. In this prospective simultaneous bilateral model
comparing the mini-subvastus and mini-midvastus ap-
proaches for total knee arthroplasty, there were no significant
differences in terms of any of the data analyzed.
Nestor et al.11 conducted a prospective, randomized,
double-blind study in which the mini-midvastus approach was
compared with the medial parapatellar approach using a si-
multaneous bilateral total knee arthroplasty model. Twenty-
seven patients participated, with the mini-midvastus approach
being used on one side and the standard medial parapatellar
approach being used on the contralateral side. Although
the authors found significantly increased isokinetic and iso-
metric extension torque at three weeks after surgery in the
mini-midvastus group, they found no differences between
the groups in terms of stride length, stance time, pain scale
scores, or knee motion after surgery. The authors concluded
that the mini-midvastus approach provided a negligible benefit
in terms of the speed of recovery and ultimate function after
total knee arthroplasty. Wu¨lker et al.12 also conducted a pro-
spective randomized study in which minimally invasive total
knee arthroplasty was compared with standard total knee ar-
throplasty. The study included 134 patients, and the authors
defined a minimally invasive approach as one associated with
an incision of <15 cm in which the surgeon used minimally
invasive instruments. Both groups were subject to the same
arthrotomy (medial parapatellar or midvastus) as the skin in-
cision and instruments were the defining qualities of a mini-
mally invasive approach. Not surprisingly, the authors found
no significant differences between the groups in terms of pain,
activities, or the Knee Society score. The conclusion that the
skin incision does not influence patient outcomes after total
knee arthroplasty is now well understood and acknowledged by
arthroplasty surgeons.
Perioperative Care
Perioperative management protocols for total knee arthro-
plasty have evolved to include not only pain management but
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also rapid ambulation protocols, blood conservation strategies,
and patient education. The beneficial effects of organized,
procedure-directed management protocols are in the process of
being described and have gained tremendous favor among
surgeons.
The effect of patient education on perioperative mile-
stones and outcomes has not been well defined. Yoon et al.13
began a one-on-one patient education program at their insti-
tution to preoperatively teach patients about arthroplasty and
appropriate expectations. Program educators followed a course
guide that reviewed the procedure and various perioperative
events and expectation, and patients were allowed to ask
questions. Although the study design could have allowed for
patient selection bias, the authors did find a one-day shorter
length of stay for patients who participated in the education
program as compared with those who did not (3.1 compared
with 4.1 days). The success of such programs appears to be
encouraging, and the cost effectiveness of such programs is
unclear.
Considering recent national guidelines regarding pre-
operative prophylactic antibiotic usage and timing, there
are surprisingly scant data driving evidence-based decision-
making. Tyllianakis et al.14 studied antibiotic usage at an
institution in Greece at which methicillin-resistant staphylo-
coccal infections represented >25% of all orthopaedic in-
fections. In that study, 470 patients were prospectively
randomized to receive cefuroxime, fusidic acid, or vancomycin
and were followed for superficial or deep infection after hip or
knee arthroplasty. The authors found no significant difference
between the antibiotic choices and concluded that they did not
recommend antistaphylococcal agents before total knee ar-
throplasty. However, considering that the authors identified
only two deep infections in the entire series, it is highly likely
that the study lacked the power to answer any questions re-
garding antibiotic use. The authors acknowledged this point
and stated that it was difficult to provide any definitive con-
clusions based on the data.
Blood management protocols attempt to limit blood loss
during total knee arthroplasty as well as to limit transfusions
after total knee arthroplasty. Efforts to increase the preopera-
tive hemoglobin level and evolving perspectives regarding the
medical need for transfusion have led to a decrease in alloge-
neic transfusions. There has been a recent growing interest in
the use of tranexamic acid to limit the bleeding and the post-
operative hemoglobin drop associated with arthroplasty. Tra-
nexamic acid can be administered parenterally or topically at
the time of surgery. Wong et al.15 addressed the efficacy of
topical tranexamic acid after total knee arthroplasty in a ran-
domized, prospective, double-blind, placebo-controlled trial.
The authors randomized 124 patients undergoing total knee
arthroplasty into three groups. The first group received 1.5 g of
tranexamic acid in 100 mL of saline solution, the second group
received 3.0 g of tranexamic acid in 100 mL of saline solution,
and the third group received 100 mL of saline solution without
drug. The treatment was applied into the knee for five minutes
at the end of surgery, and postoperative hemoglobin levels,
transfusions, and ultrasound testing for venous thrombi were
monitored. The authors found a significant drug effect, as
tranexamic acid reduced blood loss and was associated with a
higher postoperative hemoglobin level without an increase in
thrombus formation. Specifically, blood loss was reduced by
about 25% (400 mL) and postoperative hemoglobin levels were
higher by 17%. The authors also found minimal drug levels in
the blood, reflecting a very low systemic absorption. It appears
that tranexamic acid is quite effective for limiting blood loss
when applied topically during total knee arthroplasty. Another
potential method of decreasing bleeding relates to the method
of component implantation. Demey et al.16 conducted a ran-
domized study to determine whether cementing the femoral
component has any effect on blood loss. The medial para-
patellar approach was utilized on 107 patients undergoing total
knee arthroplasty who were randomized to receive a cemented
or an uncemented femoral implant. The total measured blood
loss in the study was about 1750 mL, and no significant dif-
ferences in blood loss, the transfusion rate, or hemoglobin
levels were identified. There are several reasons why surgeons
may utilize cemented femoral components; however, decreas-
ing perioperative bleeding appears not to be a valid reason.
In addition to blood management, pain control is a
main focus of a perioperative protocol. A recent trend in
anesthesia for arthroplasty is the move away from general
anesthesia toward central and peripheral strategies. Although
peripheral blocks can be effective, there remain concerns re-
garding the possibility of nerve-related complications, in-
cluding paresthesias, weakness, and, potentially, palsies.
McMeniman et al.17 specifically compared femoral nerve and
fascia iliaca anesthesia in a blinded, randomized study of
ninety-eight primary total knee arthroplasties. They found no
differences between groups in terms of the use of fentanyl
after surgery and concluded that the fascia iliaca block is as
effective as a femoral nerve block. Although not statistically
significant, the authors noted one case of femoral nerve
paresthesia in the femoral nerve block group and no nerve-
related complications in the fascia iliacus group. In addition
to the main anesthetic strategy, many groups have been pro-
ponents of periarticular injections during total knee arthro-
plasty for improved postoperative pain control. Mullaji et al.18
evaluated the efficacy of a periarticular infiltration consisting
of bupivacaine (2 mg/kg body weight), fentanyl (100 mg),
methylprednisolone acetate (40 mg), and cefuroxime (750 mg)
in a prospective, randomized study design. Forty patients un-
dergoing bilateral total knee arthroplasty agreed to have one
of the knees randomly chosen to be injected with the drug
combination during surgery. The 25-mL injection was placed
into the fat pad, posteromedial tissue sleeve, deep arthrotomy,
quadriceps tendon, and medial collateral ligament. The knees
were then followed for four weeks postoperatively and were
monitored in terms of pain, knee flexion, and quadriceps
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function. The authors found that pain scores and flexion were
superior in the injected knees for up to four weeks, whereas
quadriceps function was significantly better for two weeks.
Most interesting was the finding that pain was reduced by al-
most 50% even at the time of the four-week follow-up. Al-
though some have expressed concern regarding the effect of
steroid injection on the infection rate, the authors did not re-
port any acute postoperative infections in that study.
Two systematic reviews of prospective randomized
studies were recently conducted, one regarding cryotherapy
after total knee arthroplasty and one regarding drainage cath-
eter clamping after total knee arthroplasty. Eleven studies in-
volving 739 total knee arthroplasties were included in the
systematic review on the efficacy of cryotherapy after total knee
arthroplasty, conducted by Adie et al.19. The authors looked
specifically at blood loss, knee motion, transfusion need, pain,
analgesia requirements, swelling, and length of hospital stay.
Cryotherapy was associated with a minor decrease in blood loss
and a minor improvement in knee motion at the time of
hospital discharge, but no other clinical benefits were attrib-
utable to cryotherapy. The authors suggested that current ev-
idence does not support the use of cryotherapy after total knee
arthroplasty. In a separate systematic review, Tai et al.20 iden-
tified six randomized controlled trials (involving 603 total knee
arthroplasties) in which temporary postoperative clamping of
the drainage tube was compared with no clamping. A review of
the trials demonstrated that although clamping the drainage
tube could decrease blood loss, clamping for four hours or
more was necessary to result in a true reduction of blood loss.
Despite this finding, the authors found no significant differ-
ences between the groups with regard to transfusion, knee
motion, or wound complications.
Ergometer cycling has been suggested as one strategy to
increase patient satisfaction and health-related quality of life
after surgery. Liebs et al.21, in a randomized study of 362 pa-
tients, studied the effect of ergometer cycling beginning two
weeks after hip and knee arthroplasty. The authors found that
although ergometer cycling was associated with significant
improvements in health-related quality of life and satisfaction
after total hip replacement, the same benefit was not observed
after knee replacement.
Outcomes Studies
High-Flexion Knee Designs
Most studies to date have failed to reveal a clinical advantage to
the use of high-flexion designs for total knee arthroplasty. In
fact, some have argued that the extra bone removal may lead to
more difficult revisions that require greater use of augments.
On the other hand, there is a theoretical possibility that a long-
term benefit is found in association with high-flexion designs
that also have lower contact stresses through flexion. Choi
et al.22 conducted a randomized study comparing standard
and high-flexion knee implants that had a posterior cruciate-
retaining, rotating-platform design. They randomized 170 knees
and followed the patients for a minimum of two years, focusing
on clinical scores and radiographic outcomes. The authors
found no difference between the groups in terms of maximum
flexion or the proportion of patients who could perform activ-
ities of deep flexion. Furthermore, clinical scores and radio-
graphic findings were not different between the groups. That
study further emphasized the lack of functional benefit associ-
ated with high-flexion designs, but the long-term benefit of these
designs in terms of implant survival is unknown.
Mobile-Bearing versus Fixed-Bearing Knee Designs
Although both fixed and mobile-bearing knee replacements
have demonstrated excellent short and long-term results,
there is no clear clinical evidence supporting the superiority of
either design. The clinical equivalency between designs was
demonstrated in recent studies. Rahman et al.23, in a blinded
randomized study, evaluated fifty-one knees that were treated
with a cemented cruciate-retaining knee replacement with
either a fixed or a mobile-bearing design. The knees were
followed radiographically and clinically for a minimum of two
years. There was no demonstrable difference between the
groups in terms of clinical or functional results, and there was
no significant difference in terms of radiographic outcomes.
Although the UCLA functional score was significantly better
in the rotating-platform group, the authors believe that the
effect was due to a difference in the percentage of patients
with rheumatoid arthritis between study groups. Luna et al.24
conducted a randomized study of 312 total knee arthro-
plasties performed with either a mobile-bearing or fixed-
bearing cruciate-substituting design. They followed patients
for a minimum of two years and recorded clinical and ra-
diographic data, including Knee Society scores. At a mean of
forty-two months of follow-up, the authors demonstrated no
significant differences in terms of clinical scores, pain scores,
or radiographic findings. Again, they concluded that rotating-
platform designs do not confer a clinical advantage. In an
extensive review of the literature, Post et al.25 compared
mobile-bearing and fixed-bearing total knee arthroplasties
in terms of implant survival, clinical function, and patient
preference. Seven articles met their search criteria, and there
was no difference between implant designs with respect to
implant survival, knee motion, patient preference, or knee
scores. The authors concluded that there was no clinical su-
periority of mobile or fixed-bearing implants. Although they
do not appear to have any meaningful clinical advantages over
standard designs, mobile-bearing knees can provide excellent
long-term outcomes. In a concise follow-up study with a
minimum of twenty years of follow-up, Callaghan et al.26
reported on twenty living patients from an original cohort of
119 consecutive total knee arthroplasties that had been per-
formed with a cemented rotating-platform design. No im-
plants had been revised during the twenty-year follow-up
period, and six knees demonstrated radiographic osteolysis
(with three demonstrating more osteolysis than they had at
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the time of the fifteen year follow-up). The only reoperations
were performed for the treatment of infection (one) or peri-
prosthetic fracture (two). These results demonstrate the du-
rability and functional success of cemented rotating-platform
knees. As in previous studies with such long follow-up pe-
riods, the occurrence of osteolysis continued to increase
through the lifetime of the implant.
Total Knee Arthroplasty Outcomes
Ritter and Meneghini27 retrospectively reviewed the twenty-
year survival rate after cementless total knee arthroplasty.
Seventy-three cementless total knee replacements were im-
planted without screws from 1984 to 1986, and all patients
were followed for a minimum of ten years. Only two tibial
components failed because of aseptic loosening, at one and two
years after surgery. Unfortunately, the metal-backed patellar
component used in that series had a high failure rate, with
twelve such components requiring revision in the follow-up
period. Considering the recent interest in cementless knee re-
placement, it is encouraging to observe a series of patients with
cementless implants that fared so well. The twenty-year sur-
vival rate for the cementless tibial component was 96.8%.
Kim et al.28 conducted a prospective randomized study in
which a sex-specific total knee replacement was compared with
a standard knee replacement. Eighty-five women undergoing
bilateral total knee arthroplasty received the standard design in
one knee and the sex-specific design in the contralateral knee.
The patients were followed for a mean of two years and were
monitored with use of a variety of scoring systems and radio-
graphic reviews. Although postoperative radiographs revealed
significant improvement in matching the distal femoral aspect
ratio in association with the sex-specific implants, the authors
found no clinically relevant differences between the sex-specific
and standard designs. Longer-term follow-up is necessary to
ascertain differences in implant survival that may result from
differences in patellofemoral or posterior condylar contact
stress between designs. Interestingly, Mahoney and Kinsey29
looked specifically at femoral component overhang in relation
to outcomes after total knee arthroplasty. The investigators
intraoperatively measured femoral component medial and
lateral overhang at various points in 437 knees that had re-
ceived the same type of total knee replacement. They identified
overhang in one or more areas in 40% of male patients and
68% of female patients, most often at the distal part of the
lateral aspect of the femur. Female sex, short height, and large
femoral sizing were predictive of overhang. Importantly,
overhang of ‡3 mm was associated with an almost twofold
increase in knee pain that was more severe than occasional or
mild at two years after surgery. The clinical importance of
the distal femoral aspect ratio and implant overhang requires
further study to warrant appropriate clinical recommendations
or conclusions.
There also have been more reports in the literature
focusing on a monoblock porous metal tibial implant. Porous
metal implants, which can be made with titanium, tantalum,
and other metals, have become increasingly used for primary
and revision total knee arthroplasty. O’Keefe et al.30 reported
the minimum five-year results of 125 total knee arthroplasties
that had been performed with use of a monoblock pegged
tibial component made of porous tantalum. The plateau was
cemented and the pegged areas were left uncemented for
ingrowth. The authors reported 100% implant survival at five
years. The absence of loosening, osteolysis, or changes in
bone density are extremely encouraging for these implants;
however, larger numbers of patients are required to make
firm conclusions. Using the same implant, without cement-
ing the tibial plateau, Wilson et al.31 studied the inducible
displacement of tantalum porous metal tibial implants as
compared with standard cemented implants. They utilized
radiostereometric analysis at six, twelve, and twenty-four
months postoperatively to study fourteen tantalum porous
tibiae and eleven uncemented tibiae. The tantalum porous
metal tibial implants demonstrated a significant decrease in
inducible motion for all tests applied, suggesting excellent
fixation and likely a promising long-term prognosis. It ap-
pears that the use of porous metal ingrowth materials such as
tantalum can provide excellent fixation and intermediate-
term survival.
There has been recent discussion and controversy re-
garding the importance of the mechanical axis as the target
axis for total knee arthroplasty alignment. Although several
studies have suggested the importance of the mechanical axis
to function and implant survival after total knee arthro-
plasty, Parratte et al.32, in a report on a cohort of 398 patients,
concluded that deviation from the mechanical axis does not
cause decreased implant survival after total knee arthro-
plasty. The authors identified a group of 292 patients with
a neutral mechanical axis (an axis within 3 of neutral) and
an outlier group of 106 implants. The authors found no
significant differences between the groups in terms of the
fifteen-year Kaplan-Meier survival curves and concluded
that the mechanical axis is of little practical value as a di-
chotomous value. However, there are two main sources of
potential effect dilution that could compromise the con-
clusions. First, varus and valgus outliers were grouped to-
gether, potentially diluting any poor outcomes that could
have resulted from the knees aligned in varus. Second, the
total knee arthroplasties were performed by a master sur-
geon whose outliers were generally not considerable, leaving
a large population of outliers in the range of 4 or 5 from
neutral. Even assuming a minimal standard radiographic
measurement error of 1, the knees measured at 3 and 4
would be often misclassified, further diluting the outlier
group. Although one can likely conclude that small devia-
tions from a neutral mechanical axis are not catastrophic,
larger studies are likely more appropriate to make conclu-
sions about the relationship between implant alignment and
survival.
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